Fahad Alhumud

Fahad Alhumud

Auto-generated profile, based on publicly available information

Fahad Alhumud

Al-Ahsa Health Cluster Al-Ahsa Saudi Arabia su.edu.sa

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2023 in Anemia
Verified
Journal Article
Open access
PDF file
FKFahd Kuriri
Fahd Kuriri
AAAbdulrahman Ahmed
Abdulrahman Ahmed
FAFehaid Alanazi
Fehaid Alanazi
FAFahad Alhumud
Fahad Alhumud
MHMohammed Ageeli Hakami
Mohammed Ageeli Hakami
OAOsama Atiatalla Babiker Ahmed
Osama Atiatalla Babiker Ahmed
Introduction. The risk of developing transfusion-related complications, especially alloimmunization, is an ongoing concern for transfusion-dependent patients. It is important to determine the rate of alloimmunization and autoimmunization in Al-Ahsa Region, Saudi Arabia, where sickle cell disease (SCD) and thalassemia incidence rates are the highest in Saudi Arabia. Methods. A cross-sectional study was conducted to review the transfusion history of patients with SCD and thalassemia at the King Fahad Hospital (KFH) in Al-Ahsa, Saudi Arabia. 364 transfusion-dependent patients were included in this study. Results. Alloimmunization rates in patients with SCD and thalassemia were 16.7 and 11.97, respectively, while autoimmunization rates in patients with SCD and thalassemia were 5.3 and 0.7, respectively. The most frequent alloantibodies among the study participants were against Kell, Rh blood group systems. Conclusion. Blood transfusion-related alloimmunization and autoimmunization compromise the proper management of chronically transfused patients. Ideally, extended matched phenotyping should be implemented to prevent alloimmunization and reduce the risk of developing blood transfusion-related alloantibodies.